Previous close | 62.53 |
Open | 61.74 |
Bid | 61.25 x 100 |
Ask | 61.34 x 100 |
Day's range | 60.86 - 62.22 |
52-week range | 25.98 - 110.25 |
Volume | |
Avg. volume | 2,006,185 |
Market cap | 6.413B |
Beta (5Y monthly) | 0.68 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Cytokinetics Inc (NASDAQ:CYTK), a biopharmaceutical company focused on the discovery and development of next-generation therapeutics for muscle diseases, has reported an insider sale according to a recent SEC filing.
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
Q4 2023 CytomX Therapeutics Inc Earnings Call